METOLAZONE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
10135-766 -
Package NDC
10135-766-01 -
Package NDC
10135-766-10 -
Application number
ANDA216216 -
SPL ID
441c9c41-2125-e622-e063-6294a90adafa -
SPL set ID
efa5244a-9cdf-a806-e053-2a95a90a912e -
UNII
TZ7V40X7VX -
RxCUI
197978 -
RxCUI
197979 -
RxCUI
311671
What the source publishes
- Labeler
- Marlex Pharmaceuticals, Inc.
- Active ingredients
- metolazone
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "METOLAZONE",
"splId": "441c9c41-2125-e622-e063-6294a90adafa",
"labels": [
{
"setId": "efa5244a-9cdf-a806-e053-2a95a90a912e",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=efa5244a-9cdf-a806-e053-2a95a90a912e",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=efa5244a-9cdf-a806-e053-2a95a90a912e"
}
],
"routes": [
"ORAL"
],
"labeler": "Marlex Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (10135-766-01)",
"package_ndc": "10135-766-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20221201"
},
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (10135-766-10)",
"package_ndc": "10135-766-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20221201"
}
],
"productId": "10135-766_441c9c41-2125-e622-e063-6294a90adafa",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "10135-766",
"deaSchedule": null,
"genericName": "metolazone",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "METOLAZONE",
"strength": "5 mg/1"
}
],
"applicationNumber": "ANDA216216",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20221201",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175359",
"N0000175420"
],
"unii": [
"TZ7V40X7VX"
],
"rxcui": [
"197978",
"197979",
"311671"
],
"spl_set_id": [
"efa5244a-9cdf-a806-e053-2a95a90a912e"
],
"pharm_class_pe": [
"Increased Diuresis [PE]"
],
"pharm_class_epc": [
"Thiazide-like Diuretic [EPC]"
],
"manufacturer_name": [
"Marlex Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:10135-766_441c9c41-2125-e622-e063-6294a90adafa"